BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  MicroGenDX Launches “Rapid H5,” a PCR Test for H5 Influenza Detection

  March 3, 2025

   · 

  2 min read
• Press Releases

  Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 28, 2025

  March 3, 2025

   · 

  2 min read
• Press Releases

  Celldex Therapeutics Presents Positive Results from Barzolvolimab Phase 2 Studies in Patients with Chronic Urticaria Demonstrating Improved Disease Control and Quality of Life at AAAAI 2025

  March 3, 2025

   · 

  9 min read
• Press Releases

  POSITIVE RESULTS FROM TEZSPIRE® (TEZEPELUMAB-EKKO) PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS

  March 3, 2025

   · 

  23 min read
• Press Releases

  The Committee for Medicinal Products for Human Use (CHMP) Reaffirms Positive Opinion for Lecanemab in Early Alzheimer’s Disease

  March 3, 2025

   · 

  9 min read
• Press Releases

  WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.

  March 3, 2025

   · 

  5 min read
• Press Releases

  Palforzia® Oral Immunotherapy for the Treatment of Peanut Allergy Now Available in the U.S. for Pediatric Ages 1 Through 3 Years

  March 3, 2025

   · 

  4 min read
• Press Releases

  Valneva Receives EMA’s Positive CHMP Opinion for Adolescent Label Extension for Chikungunya Vaccine IXCHIQ®

  March 3, 2025

   · 

  10 min read
• Press Releases

  Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives

  March 3, 2025

   · 

  2 min read
• Press Releases

  Positive results from the TEZSPIRE Phase III WAYPOINT trial highlight rapid and sustained effect in chronic rhinosinusitis with nasal polyps

  March 3, 2025

   · 

  14 min read